We are live on ! Find out more
C

Chescapmanager Portfolio holdings

AUM $1.12B
1-Year Est. Return 67.49%
This Fund
S&P 500
This Quarter Est. Return
+2.72%
1 Year Est. Return
+67.49%
3 Year Est. Return
+215.18%
5 Year Est. Return
+141.46%
10 Year Est. Return
AUM
$1B
AUM Growth
+$161M
Cap. Flow
+$142M
Cap. Flow %
14.18%
Top 10 Hldgs %
68.21%
Holding
54
New
12
Increased
8
Reduced
14
Closed
15

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$27.3M
2
AMZN icon
Amazon
AMZN
+$11.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$10.1M
4
USG
Usg
USG
+$7.01M
5
MGM icon
MGM Resorts International
MGM
+$6.68M

Sector Composition

Rank Sector Weight
1 Healthcare 25.64%
2 Consumer Discretionary 10.26%
3 Industrials 6.03%
4 Materials 3.69%
5 Communication Services 2.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLF icon
51
CALL
State Street Financial Select Sector SPDR ETF
XLF
$56.5B
-500,000
Closed -$12.9M
VSM
52
DELISTED
Versum Materials, Inc.
VSM
-10,000
Closed -$503K
USG
53
DELISTED
Usg
USG
-161,889
Closed -$7.01M
CELG
54
PUT
DELISTED
Celgene Corp
CELG
-20,000
Closed -$1.89M

Similar funds

Chescapmanager's Q2 2019 Portfolio in Review

As of Q2 2019, Chescapmanager held 54 positions worth $1B, up 19% from $842M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Chescapmanager deployed $142M of net new capital in Q2 2019, opening 12 new positions and adding to 8 existing holdings. Its largest new stake was Celgene Corp: 285,852 shares worth $26.4M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Amazon, an estimated $11.2M trimmed.

  • Chescapmanager's largest Q2 2019 buy was Celgene Corp: 285,852 shares worth $26.4M.
  • Chescapmanager added most to First Data Corporation in Q2 2019, an estimated $17M increase.
  • Chescapmanager's biggest Q2 2019 reduction was Amazon, cutting an estimated $11.2M.
  • Chescapmanager fully exited Bristol-Myers Squibb in Q2 2019, selling an estimated $27.3M.
  • Chescapmanager's ten largest holdings make up 68% of its $1B portfolio in Q2 2019.
  • Chescapmanager opened 12 new positions and closed 15 in Q2 2019.
  • Chescapmanager's portfolio value rose 19% quarter-over-quarter to $1B.

Based on Chescapmanager's 13F filing for Q2 2019, filed 14 Aug 2019.